ORAL PRESENTATIONS: Saturday, 22 April 2017: Late breakers: OralsLBO-03 - MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infection
References (0)
Cited by (0)
Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.